The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bisphosphonate Drug-Global Market Insights and Sales Trends 2025
Synopsis
Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonate Drug market size is expected to reach US$ 1241.1 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Bisphosphonate Drug in various end use industries. The expanding demands from the Postmenopausal Osteoporosis, Men with Osteoporosis, Paget’s Disease and Bone Loss Caused by Cancer Treatment, are propelling Bisphosphonate Drug market. Alendronate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Risedronate segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bisphosphonate Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bisphosphonate Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bisphosphonate Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bisphosphonate Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bisphosphonate Drug covered in this report include Merck, Teva, Mylan, Apotex Corp, Cobalt Pharmaceuticals, Genentech, Novartis Pharmaceuticals and Sanofi-Aventis, etc.
The global Bisphosphonate Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Global Bisphosphonate Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bisphosphonate Drug market, Segment by Type:
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug
Global Bisphosphonate Drug market, by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Paget’s Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bisphosphonate Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bisphosphonate Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonate Drug market size is expected to reach US$ 1241.1 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Bisphosphonate Drug in various end use industries. The expanding demands from the Postmenopausal Osteoporosis, Men with Osteoporosis, Paget’s Disease and Bone Loss Caused by Cancer Treatment, are propelling Bisphosphonate Drug market. Alendronate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Risedronate segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bisphosphonate Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bisphosphonate Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bisphosphonate Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bisphosphonate Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bisphosphonate Drug covered in this report include Merck, Teva, Mylan, Apotex Corp, Cobalt Pharmaceuticals, Genentech, Novartis Pharmaceuticals and Sanofi-Aventis, etc.
The global Bisphosphonate Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Global Bisphosphonate Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bisphosphonate Drug market, Segment by Type:
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug
Global Bisphosphonate Drug market, by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Paget’s Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bisphosphonate Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bisphosphonate Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Bisphosphonate Drug Market Overview
1.1 Bisphosphonate Drug Product Overview
1.2 Bisphosphonate Drug Market Segment by Type
1.2.1 Alendronate
1.2.2 Risedronate
1.2.3 Zoledronic Acid
1.2.4 Other Bisphosphonate Drug
1.3 Global Bisphosphonate Drug Market Size by Type
1.3.1 Global Bisphosphonate Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Bisphosphonate Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bisphosphonate Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bisphosphonate Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bisphosphonate Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bisphosphonate Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bisphosphonate Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bisphosphonate Drug Sales Breakdown by Type (2018-2023)
2 Global Bisphosphonate Drug Market Competition by Company
2.1 Global Top Players by Bisphosphonate Drug Sales (2018-2023)
2.2 Global Top Players by Bisphosphonate Drug Revenue (2018-2023)
2.3 Global Top Players by Bisphosphonate Drug Price (2018-2023)
2.4 Global Top Manufacturers Bisphosphonate Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bisphosphonate Drug Market Competitive Situation and Trends
2.5.1 Bisphosphonate Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bisphosphonate Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bisphosphonate Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Bisphosphonate Drug Market
2.8 Key Manufacturers Bisphosphonate Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bisphosphonate Drug Status and Outlook by Region
3.1 Global Bisphosphonate Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bisphosphonate Drug Historic Market Size by Region
3.2.1 Global Bisphosphonate Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Bisphosphonate Drug Sales in Value by Region (2018-2023)
3.2.3 Global Bisphosphonate Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bisphosphonate Drug Forecasted Market Size by Region
3.3.1 Global Bisphosphonate Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Bisphosphonate Drug Sales in Value by Region (2024-2029)
3.3.3 Global Bisphosphonate Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bisphosphonate Drug by Application
4.1 Bisphosphonate Drug Market Segment by Application
4.1.1 Postmenopausal Osteoporosis
4.1.2 Men with Osteoporosis
4.1.3 Paget’s Disease
4.1.4 Bone Loss Caused by Cancer Treatment
4.1.5 Osteoporosis Imperfecta in Children
4.2 Global Bisphosphonate Drug Market Size by Application
4.2.1 Global Bisphosphonate Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Bisphosphonate Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bisphosphonate Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bisphosphonate Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bisphosphonate Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bisphosphonate Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bisphosphonate Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bisphosphonate Drug Sales Breakdown by Application (2018-2023)
5 North America Bisphosphonate Drug by Country
5.1 North America Bisphosphonate Drug Historic Market Size by Country
5.1.1 North America Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bisphosphonate Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Bisphosphonate Drug Sales in Value by Country (2018-2023)
5.2 North America Bisphosphonate Drug Forecasted Market Size by Country
5.2.1 North America Bisphosphonate Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Bisphosphonate Drug Sales in Value by Country (2024-2029)
6 Europe Bisphosphonate Drug by Country
6.1 Europe Bisphosphonate Drug Historic Market Size by Country
6.1.1 Europe Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bisphosphonate Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Bisphosphonate Drug Sales in Value by Country (2018-2023)
6.2 Europe Bisphosphonate Drug Forecasted Market Size by Country
6.2.1 Europe Bisphosphonate Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Bisphosphonate Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Bisphosphonate Drug by Region
7.1 Asia-Pacific Bisphosphonate Drug Historic Market Size by Region
7.1.1 Asia-Pacific Bisphosphonate Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bisphosphonate Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bisphosphonate Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bisphosphonate Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Bisphosphonate Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bisphosphonate Drug Sales in Value by Region (2024-2029)
8 Latin America Bisphosphonate Drug by Country
8.1 Latin America Bisphosphonate Drug Historic Market Size by Country
8.1.1 Latin America Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bisphosphonate Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bisphosphonate Drug Sales in Value by Country (2018-2023)
8.2 Latin America Bisphosphonate Drug Forecasted Market Size by Country
8.2.1 Latin America Bisphosphonate Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bisphosphonate Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Bisphosphonate Drug by Country
9.1 Middle East and Africa Bisphosphonate Drug Historic Market Size by Country
9.1.1 Middle East and Africa Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bisphosphonate Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bisphosphonate Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bisphosphonate Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Bisphosphonate Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bisphosphonate Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Bisphosphonate Drug Products Offered
10.1.5 Merck Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Bisphosphonate Drug Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Bisphosphonate Drug Products Offered
10.3.5 Mylan Recent Development
10.4 Apotex Corp
10.4.1 Apotex Corp Company Information
10.4.2 Apotex Corp Introduction and Business Overview
10.4.3 Apotex Corp Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Apotex Corp Bisphosphonate Drug Products Offered
10.4.5 Apotex Corp Recent Development
10.5 Cobalt Pharmaceuticals
10.5.1 Cobalt Pharmaceuticals Company Information
10.5.2 Cobalt Pharmaceuticals Introduction and Business Overview
10.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Products Offered
10.5.5 Cobalt Pharmaceuticals Recent Development
10.6 Genentech
10.6.1 Genentech Company Information
10.6.2 Genentech Introduction and Business Overview
10.6.3 Genentech Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Genentech Bisphosphonate Drug Products Offered
10.6.5 Genentech Recent Development
10.7 Novartis Pharmaceuticals
10.7.1 Novartis Pharmaceuticals Company Information
10.7.2 Novartis Pharmaceuticals Introduction and Business Overview
10.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novartis Pharmaceuticals Bisphosphonate Drug Products Offered
10.7.5 Novartis Pharmaceuticals Recent Development
10.8 Sanofi-Aventis
10.8.1 Sanofi-Aventis Company Information
10.8.2 Sanofi-Aventis Introduction and Business Overview
10.8.3 Sanofi-Aventis Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi-Aventis Bisphosphonate Drug Products Offered
10.8.5 Sanofi-Aventis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bisphosphonate Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bisphosphonate Drug Industrial Chain Analysis
11.4 Bisphosphonate Drug Market Dynamics
11.4.1 Bisphosphonate Drug Industry Trends
11.4.2 Bisphosphonate Drug Market Drivers
11.4.3 Bisphosphonate Drug Market Challenges
11.4.4 Bisphosphonate Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bisphosphonate Drug Distributors
12.3 Bisphosphonate Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
